Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Healthcapital is a Swiss-based, internationally operating biotech investment and advisory company focused on life sciences and healthcare. Historically referred to as BSI Healthcapital SA, it appears to have operated as the biotech investment and healthcare management arm of BSI SA and later continued under the name Healthcapital SA. The firm focuses on investing in private biotech companies developing new drug candidates or technologies that remove bottlenecks in drug development, while also offering strategic counseling and healthcare policy advisory services. Its website emphasizes biotech investments, corporate finance, and a global healthcare policy think-tank rather than in-house drug development. Disclosed historical investments include companies in oncology, infectious disease, urology-focused specialty pharma, and ophthalmic devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Healthcapital.